MicroRNA-486–dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy–associated symptomsMatthew S. Alexander, Louis M. Kunkel, Fedik Rahimov et al.|Journal of Clinical Investigation|2014Cited by 152
A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathiesPeter R. Serafini, Matthew S. Alexander, Devin Gibbs et al.|JCI Insight|2018Cited by 22